Clinical Trial Update: A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function [Phase 2]

View source ↗

Summary

Phase 2 proof-of-principle trial investigating NNC0114-0006 and liraglutide for preservation of beta-cell function in adults with newly diagnosed type 1 diabete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• NNC0114-0006
• liraglutide (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED | Results posted: 2021-01-11